Michigan loses $3M on drug manufacturing try; API maker Croda buys a biotech firm;

> The University of Michigan expects to lose $120,000 next year, on top of $3.028 million this year, invested in an effort to get a Department of Defense contract to manufacture products at a former Pfizer ($PFE) site. Story

> A trade association in Africa says if countries there would invest more in research and development they would get better manufacturing as a side benefit. Article

> Chemicalmaker Croda has paid £5.9 million ($9.2 million) to buy the Italian biotech company Istituto di Ricerche Biotecnologiche and will merge it with its Sederma skin care business. Release

> Growth of 13% the unit that includes API sales at Albemarle helped buffer the overall 8% fall in revenue in the second quarter. Story

And Finally... The SME Pharma Industries Confederation (SPIC) in India is pushing the government even the tax burden for all contract manufacturing organizations, saying that those in tax-free zones are getting 70% of all contracts. Story

Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.